Relapse Prevention Study in Newly Abstinent Smokers

NCT00793468 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study halted prior to enrollment of patients

Conditions

Substance Dependence

Interventions

DRUG: GSK598809
DRUG: Nicotine Replacement Transdermal Patch
DRUG: Placebo

Sponsor

GlaxoSmithKline